ASUR vs AVGO

ASUR exhibits a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to assess bankruptcy risk. Despite strong revenue growth of 23.7% and a bullish analyst recommendation (strong_buy), the company is unprofitable with negative profit and operating margins, weak cash conversion, and deteriorating earnings quality. While forward valuation metrics appear reasonable at a Forward P/E of 10.14, the stock trades below its 52-week high and has underperformed peers, offset by improving recent EPS trends and insider sentiment of 60/100. The absence of key financial data (e.g., cash, debt, EV) limits conviction, warranting caution despite growth signals.

Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.